Aardvark Therapeutics, Inc.
AARD
$4.11
-$0.43-9.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -131.88% | -100.46% | -290.15% | -163.66% | -327.46% |
| Total Depreciation and Amortization | 120.00% | 25.00% | 25.00% | 650.00% | 150.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 624.45% | 533.62% | 273.02% | 101.59% | -10.16% |
| Change in Net Operating Assets | 130.67% | -182.58% | -940.63% | 273.83% | -638.87% |
| Cash from Operations | -65.69% | -117.55% | -307.84% | -133.55% | -420.00% |
| Capital Expenditure | -- | 100.00% | 20.00% | 2.15% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 130.41% | 304.41% | -- | -- | -- |
| Cash from Investing | 130.41% | 304.30% | 585,020.00% | 10,217.20% | -2,252,380.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 68.10% | 1.18% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 96.26% | -- |
| Cash from Financing | -100.00% | 127.02% | 167.19% | -100.09% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.79% | 137.63% | 441.04% | -100.64% | -1,500.77% |